Switch to
More onapp

How to use scorecard? Learn more

Jubilant Pharmova Ltd

JUBLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,493 cr, stock is ranked 481
High RiskStock is 3.52x as volatile as Nifty
725.854.15 (+0.58%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,493 cr, stock is ranked 481
High RiskStock is 3.52x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
149.08
PB RatioPB Ratio
2.13
Dividend YieldDiv. Yield
0.69%
Sector PESector PE
45.17
Sector PBSector PB
6.11
Sector Div YldSctr Div Yld
0.56%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jubilant Life Sciences Limited is a pharmaceutical and life sciences company.

Brands

Jubilant Life Sciences

Pharmaceutical company

Brands

Jubilant Life Sciences

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320246.396.146.336.800.840.41-0.060.08
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnJun 26, 2024

Jubilant Pharmova Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | Download

Jubilant Pharmova Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | Download

Loss/Duplicate-Share Certificate-XBRL 
Announced OnJun 25, 2024

Jubilant Pharmova Limited has informed the Exchange about Loss of share certificates | Download

Jubilant Pharmova Limited has informed the Exchange about Loss of share certificates | Download

Cash Dividend 
Ex. DateAug 10, 2023

Final • Div/Share: ₹ 5

See all events